Floatz logo

PROPOFOL

Spine Deformity

Medical College of WisconsinSmall moleculePhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

12 Active assets in the Spine Deformity cohort.

Asset / SponsorPhaseRating
Oxycodone
Grünenthal GmbH
Phase 4BBB
Glycopyrrolate
Medical College of Wisconsin
Phase 4BB
Bxcl501
Medical College of Wisconsin
Phase 4BB
DINITROGEN MONOXIDE
Medical College of Wisconsin
Phase 4BB
NEPENTHE
MedtronicNeuro
Phase 4BB

View all 41 →

Same molecule, other indications

PROPOFOL is also rated in:

Pain, ChronicDormant
BBB
Indicative ·
79 / 100
View asset →
headache disorderDormant
BBB
Indicative ·
73 / 100
View asset →
morbid obesityDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →